Frontiers in nutrition · 2025
Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviews.
СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Petakh Pavlo, Kamyshna Iryna, Halabitska Iryna, Kamyshnyi Oleksandr
Аннотация
BACKGROUND: Vitamin D is suggested as a supportive therapy to reduce the severity of COVID-19 due to its immunomodulatory and anti-inflammatory effects. However, its effect on critical outcomes, such as ICU admissions and mortality, shows significant variation across randomized clinical trials and meta-analyses.
OBJECTIVES: To summarize the influence of vitamin D supplementation on ICU admissions and mortality among COVID-19 patients.
METHODS: Overall, 21 eligible studies were retrieved using a comprehensive search from Scopus, PubMed, and Web of Science. A citation matrix was developed, revealing a Corrected Covered Area (CCA) of 0.54, indicating moderate overlap. Fixed-effects models were applied to data with low heterogeneity (ICU admissions: Q = 10.87, p = 0.33), while random-effects models were used for mortality outcomes (Q = 27.23, p = 0.006). Pooled odds ratios (OR) with 95% confidence intervals (CI) quantified the overall effects.
RESULTS: Vitamin D supplementation was associated with a significant 38% reduction in ICU admissions (OR = 0.62; 95% CI: 0.54-0.71) and a 33% reduction in mortality risk (OR = 0.67; 95% CI: 0.56-0.79). The benefit was pronounced in vitamin D-deficient populations, although heterogeneity in mortality outcomes highlighted variability across studies.
CONCLUSION: While these findings suggest that vitamin D supplementation may help reduce ICU admissions and mortality among COVID-19 patients-particularly in those with vitamin D deficiency-the results should be interpreted with caution. The observed variability and potential confounding factors underscore the need for further large-scale, randomized controlled trials with standardized dosing protocols before definitive clinical recommendations can be made.
OBJECTIVES: To summarize the influence of vitamin D supplementation on ICU admissions and mortality among COVID-19 patients.
METHODS: Overall, 21 eligible studies were retrieved using a comprehensive search from Scopus, PubMed, and Web of Science. A citation matrix was developed, revealing a Corrected Covered Area (CCA) of 0.54, indicating moderate overlap. Fixed-effects models were applied to data with low heterogeneity (ICU admissions: Q = 10.87, p = 0.33), while random-effects models were used for mortality outcomes (Q = 27.23, p = 0.006). Pooled odds ratios (OR) with 95% confidence intervals (CI) quantified the overall effects.
RESULTS: Vitamin D supplementation was associated with a significant 38% reduction in ICU admissions (OR = 0.62; 95% CI: 0.54-0.71) and a 33% reduction in mortality risk (OR = 0.67; 95% CI: 0.56-0.79). The benefit was pronounced in vitamin D-deficient populations, although heterogeneity in mortality outcomes highlighted variability across studies.
CONCLUSION: While these findings suggest that vitamin D supplementation may help reduce ICU admissions and mortality among COVID-19 patients-particularly in those with vitamin D deficiency-the results should be interpreted with caution. The observed variability and potential confounding factors underscore the need for further large-scale, randomized controlled trials with standardized dosing protocols before definitive clinical recommendations can be made.